AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.
The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
A new study revealing how ovarian cancer cells adapt to their environment to aid tumour growth brings researchers closer to developing targeted treatments.
The team at Rush University Medical Center have conducted the first US investigation into opioid use and pancreatic cancer - how could this change prescriptions?
UK Research and Innovation (UKRI) has awarded £3.5 million-worth of funding to help ground-breaking medical research find new ways to diagnose lung cancer earlier.
Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.
CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.
Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.
Zisis Kozlakidis, International Agency for Research on Cancer and Chite Asirwa, International Cancer Institute, walk us through the cancer challenges in Sub-Saharan Africa today.
Leading pancreatic cancer experts Professor Matthias Löhr and Professor Monique van Leerdam of United European Gastroenterology’s (UEG) Public Affairs Committee discuss the importance of early diagnosis and the latest developments in treatment for pancreatic cancer.
Muy-Teck Teh, Senior Lecturer from Barts and the London School of Medicine & Dentistry, Queen Mary University of London discusses how a novel low-cost rapid digital diagnostic test could help save lives and reduce head and neck cancer burden worldwide.
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Zisis Kozlakidis from the International Agency for Research on Cancer and Symeon Psomiadis from the University of Athens, Greece lift the lid on digital health and cancer, including how remote care is being supported during COVID-19.
